RLAY

Relay Therapeutics, Inc.NASDAQHealthcare

$12.54+16.43%ClosedMarket Cap: $2.24B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-23	HC Wainwright & Co.	—	Buy	—
2026-03-17	Wells Fargo	—	Overweight	—
2026-03-17	Citizens	—	Market Outperform	—
2026-03-13	Guggenheim	—	Buy	—
2026-01-26	Oppenheimer	—	Outperform	—
2025-12-12	Wells Fargo	—	Overweight	—
2025-11-07	Wells Fargo	—	Equal Weight	—
2025-08-26	HC Wainwright & Co.	—	Buy	—
2025-08-08	Raymond James	—	Strong Buy	—
2025-05-07	Guggenheim	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-1.48	$21.9M	5
Sun Dec 31	$-1.42	$27.4M	5
Mon Dec 31	$-1.15	$112.4M	1
Tue Dec 31	$-0.43	$340.0M	1